Another good article on Pharmaceutical companies unleashing the power of Stem Cells and increasing their research as a new wave of the future. I will comment further but it was a good read on things to come.
Pharma's R&D Focus Shifting to Stem Cells
Susan Aldridge, Ph.D.
Investors' Interest in These Cells Increases as Scientists Continue to Unleash Their Potential
Stem cells could replace and potentially improve upon at least some in vivo models in drug discovery and development. That was a key message from the “World Stem Cells and Regenerative Medicine Congress” held recently in London.
“There is a major focus now on stem cells in pharma R&D with the major investors showing an interest,” according to Ian Cotgreave, Ph.D., director of molecular toxicology and safety assessment at AstraZeneca. He noted that pharma’s current focus is on cardiomyocytes and hepatocytes, as well as on differentiation protocols and understanding phenotypic progression.
